Your browser doesn't support javascript.
loading
Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study.
Zhu, Meng; Xu, Kuanfeng; Chen, Yang; Gu, Yong; Zhang, Mei; Luo, Feihong; Liu, Yu; Gu, Wei; Hu, Ji; Xu, Haixia; Xie, Zhiguo; Sun, Chengjun; Li, Yuxiu; Sun, Min; Xu, Xinyu; Hsu, Hsiang-Ting; Chen, Heng; Fu, Qi; Shi, Yun; Xu, Jingjing; Ji, Li; Liu, Jin; Bian, Lingling; Zhu, Jing; Chen, Shuang; Xiao, Lei; Li, Xin; Jiang, Hemin; Shen, Min; Huang, Qianwen; Fang, Chen; Li, Xia; Huang, Gan; Fan, Jingyi; Jiang, Zhu; Jiang, Yue; Dai, Juncheng; Ma, Hongxia; Zheng, Shuai; Cai, Yun; Dai, Hao; Zheng, Xuqin; Zhou, Hongwen; Ni, Shining; Jin, Guangfu; She, Jin-Xiong; Yu, Liping; Polychronakos, Constantin; Hu, Zhibin; Zhou, Zhiguang.
Afiliação
  • Zhu M; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xu K; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • Chen Y; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Gu Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang M; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Luo F; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Liu Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Gu W; Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University, Shanghai, China.
  • Hu J; Department of Endocrinology and Metabolism, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
  • Xu H; Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Xie Z; Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Sun C; Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li Y; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Sun M; National Clinical Research Center for Metabolic Diseases, Changsha, China.
  • Xu X; Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China.
  • Hsu HT; Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University, Shanghai, China.
  • Chen H; Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Fu Q; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Shi Y; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xu J; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Ji L; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Liu J; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Bian L; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhu J; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Chen S; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xiao L; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Jiang H; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Shen M; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Huang Q; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Fang C; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li X; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Huang G; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Fan J; Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Jiang Z; Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Jiang Y; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Dai J; National Clinical Research Center for Metabolic Diseases, Changsha, China.
  • Ma H; Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China.
  • Zheng S; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Cai Y; National Clinical Research Center for Metabolic Diseases, Changsha, China.
  • Dai H; Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, Changsha, China.
  • Zheng X; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • Zhou H; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • Ni S; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • Jin G; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • She JX; State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China.
  • Yu L; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Polychronakos C; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Hu Z; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhou Z; Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Diabetes Care ; 42(8): 1414-1421, 2019 08.
Article em En | MEDLINE | ID: mdl-31152121
OBJECTIVE: Type 1 diabetes (T1D) is a highly heritable disease with much lower incidence but more adult-onset cases in the Chinese population. Although genome-wide association studies (GWAS) have identified >60 T1D loci in Caucasians, less is known in Asians. RESEARCH DESIGN AND METHODS: We performed the first two-stage GWAS of T1D using 2,596 autoantibody-positive T1D case subjects and 5,082 control subjects in a Chinese Han population and evaluated the associations between the identified T1D risk loci and age and fasting C-peptide levels at T1D diagnosis. RESULTS: We observed a high genetic correlation between children/adolescents and adult T1D case subjects (r g = 0.87), as well as subgroups of autoantibody status (r g ≥ 0.90). We identified four T1D risk loci reaching genome-wide significance in the Chinese Han population, including two novel loci, rs4320356 near BTN3A1 (odds ratio [OR] 1.26, P = 2.70 × 10-8) and rs3802604 in GATA3 (OR 1.24, P = 2.06 × 10-8), and two previously reported loci, rs1770 in MHC (OR 4.28, P = 2.25 × 10-232) and rs705699 in SUOX (OR 1.46, P = 7.48 × 10-20). Further fine mapping in the MHC region revealed five independent variants, including another novel locus, HLA-C position 275 (omnibus P = 9.78 × 10-12), specific to the Chinese population. Based on the identified eight variants, we achieved an area under the curve value of 0.86 (95% CI 0.85-0.88). By building a genetic risk score (GRS) with these variants, we observed that the higher GRS were associated with an earlier age of T1D diagnosis (P = 9.08 × 10-11) and lower fasting C-peptide levels (P = 7.19 × 10-3) in individuals newly diagnosed with T1D. CONCLUSIONS: Our results extend current knowledge on genetic contributions to T1D risk. Further investigations in different populations are needed for genetic heterogeneity and subsequent precision medicine.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD / Fatores Etários / Diabetes Mellitus Tipo 1 / Fator de Transcrição GATA3 / Loci Gênicos / Butirofilinas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Diabetes Care Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD / Fatores Etários / Diabetes Mellitus Tipo 1 / Fator de Transcrição GATA3 / Loci Gênicos / Butirofilinas Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Diabetes Care Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China